A public health approach to “prevention with positives”: The new york state HIV\AIDS service delivery system

Journal of Public Health Management and Practice

Volumn 11, Issue 1, 2005, Pages 7-17

  Klein, Susan J ^a   Cruz, Humberto ^a   O’connell, Daniel A ^a   Scully, Mona A ^a   Birkhead, Guthrie S ^b  

^a NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

HIV prevention; HIV transmission; prevention with positives

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; HEALTH CARE PLANNING; HEALTH SERVICES RESEARCH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METHODOLOGY; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; UNITED STATES;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CONTINUITY OF PATIENT CARE; HEALTH PRIORITIES; HIV INFECTIONS; HUMANS; NEW YORK; ORGANIZATIONAL CASE STUDIES; PREVENTIVE HEALTH SERVICES; PUBLIC HEALTH ADMINISTRATION;

EID: 13844319762     PISSN: 10784659     EISSN: 15505022     Source Type: Journal    
DOI: 10.1097/00124784-200501000-00003     Document Type: Article

References (59)

1. Centers for Disease Control and Prevention. Advancing HIV prevention: new strategies for a changing epidemic—United States, 2003. Morbidity and Mortality Weekly Report. 2003;52(15):329-332
2. Centers for Disease Control and Prevention Advancing HIV prevention: new strategies for a changing epidemicUnited States, 2003. Morbidity and Mortality Weekly Report 2003 52 15 329-332
3. Centers for Disease Control and Prevention. HIV prevention case management guidance. 1997. Available at: http://www.cdc.gov/hiv/pubs/hivpcmg.htm. Accessed December 15, 2003.
4. Centers for Disease Control and Prevention. Revised guidelines for hiv counseling, testing and referral and revised recommendations for HIV screening of pregnant women. Morbidity and Mortality Weekly Report. 2001;50(RR-19):1-95. Available at: http://www.cdc.gov/mmwr/pdf/rr/rr5019.pdf.
5. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV. Morbidity and Mortality Weekly Report. 2003;52(RR12):1-24.
6. Centers for Disease Control and Prevention Incorporating HIV prevention into the medical care of persons living with HIV. Morbidity and Mortality Weekly Report 2003 52 1-24
7. Janssen RS, Holtgrave DR, Valdiserri RO, Shepherd M, Gayle HD, DeCock KM. The Serostatus approach to fighting the hiv epidemic: prevention strategies for infected individuals. American Journal of Public Health. 2001;91(7):1019-1024.
8. Committee for the Study of the Future of Public Health, Division of Health Care Services, Institute of Medicine. The Future of Public Health. Washington, DC: National Academy Press; 1998.
9. Centers for Disease Control and Prevention. Kaposi’s sarcoma and pneumocystis pneumonia among homosexual men—New York City and California. Morbidity and Mortality Weekly Report. 1981;4(30):306-308.
10. Centers for Disease Control and Prevention Kaposis sarcoma and pneumocystis pneumonia among homosexual menNew York City and California. Morbidity and Mortality Weekly Report 1981 4 30 306-308
11. Centers for Disease Control and Prevention. U.S. HIV and AIDS cases reported through December 2001. HIV/AIDS Surveillance Report. 2003;13(2):7-11.
12. Centers for Disease Control and Prevention U.S. HIV and AIDS cases reported through December 2001. HIV/AIDS Surveillance Report 2003 13 2 7-11
13. New York State Department of Health, Bureau of HIV/AIDS Epidemiology. New York State HIV/AIDS Surveillance Semiannual Report For Cases Diagnosed through December 31, 2001. Albany NY: New York State Department of Health, Bureau of HIV/AIDS Epidemiology; 2003.
14. New York State Department of Health. AIDS in New York State, 2001-02 [ed. covering data reported through December 1999]. Albany NY: New York State Department of Health; 2002.
15. NYS Public Health Law, Article 27-E. Available at: http://public.leginfo.state.ny.us/menugetf.cgi. Accessed December 15, 2003.
16. Rango NA, Rampolla M. Expanding the Focus of Human Immunodeficiency Virus Prevention in the 1990s. New York State Journal of Medicine. 1990; 90:16-119.
17. Intergovernmental Health Policy Project. AIDS A Public Health Challenge, State Issues, Policies and Programs, Volume 1: Assessing the Problem. Washington DC: The George Washington University; October 1987.
18. Altfeld M, Allen TM, Yu XG, et al. HIV-1 Superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature. 2002;420:434-439.
19. Jost S, Bernard M-C, Kaiser L, et al. A Patient with HIV-1 Superinfection. NEJM. 2002;347(10):731-736.
20. Ramos A, Hu DL, Nguyen L, et al. Inter-subtype HIV-1 Superinfection following Seroconversion to Primary Infection in two IDUs. J Virol. 2002;76:7444-7452.
21. New York State AIDS Advisory Council. Report on Needle Exchange Programs and Deregulation of Needles and Syringes, The New York State AIDS Advisory Council, April 1996. Albany, NY: New York State AIDS Advisory Council; 1996.
22. New York State AIDS Advisory Council. Findings of the HIV Surveillance Workgroup, April 1998. Albany, NY: New York State AIDS Advisory Council; 1998.
23. New York State AIDS Advisory Council. Report of the Ethical Issues in Access to HIV Treatment Workgroup, September 1998. Albany, NY: New York State Aids Advisory Council; 1998.
24. Noring S, Dubler NN, Birkhead GS, Agins B. A new paradigm for HIV care: ethical and clinical considerations. Am J Public Health. 2001;91:690-694.
25. New York State AIDS Advisory Council. Report on HIV/AIDS Services in New York State Correctional Facilities, February 1999. Albany, NY: New York State AIDS Advisory Council; 1999.
26. New York State AIDS Advisory Council. Communities at Risk: HIV/AIDS in Communities of Color, Winter 2001-2001. Albany, NY: New York State AIDS Advisory Council; 2001.
27. New York State Department of Health. AIDS: New York’s Response, A 5-Year Interagency Plan, January 1989. Albany, NY: New York State Department of Health; 1989.
28. New York State Department of Health. New York State Interagency Task Force on HIV/AIDS: Final Report to the Governor, April 2000. Albany, NY: New York State Department of Health; 2000.
29. New York State Department of Health. New York State Interagency Task Force on HIV/AIDS: Service Program & Policy Inventory 2000. Albany, NY: New York State Department of Health; 2000.
30. Feldman I, Cruz H, DeLorenze J, Hidalgo J, Plavin H, Whiitaker J. Developing a managed care delivery system in New York State for Medicaid recipients with HIV. The American Journal of Managed Care. 1999;5(11):1457-1465.
31. Herek GM. AIDS and stigma. American Behavioral Scientist. 1999;42(7):1106-1116.
32. Herek G, Capitano JP, Widaman KF. HIV-related stigma and knowledge in the United States: revalence and trends, 1991-1999. American Journal of Public Health. 2002;92(3):371-377.
33. Committee on HIV Prevention Strategies in the United States, Division of Health Promotion and Disease Prevention, Institute of Medicine. No Time to Lose: Getting More From HIV Prevention. Washington, DC: National Academy Press; 2001.
34. NYS Public Health Law. Article 27-F. http://leginfo.state.ny.us:82/menugetf.cgi. Accessed December 18, 2001.
35. Klein SJ, Karchner WD, O’Connell DA. Interventions to prevent HIV-Related stigma and discrimination: findings and recommendations for public health practice. Journal of Public Health Management and Practice. 2002;8(6):44-53.
36. New York State Department of Health, AIDS Institute. HIV & Primary Care: Putting Prevention into Practice. Albany NY: New York State Department of Health AIDS Institute; 1998.
37. New York State Department of Health, AIDS Institute. Directory of Resources and Services 2001. Albany NY: New York State Department of Health AIDS Institute; 2001.
38. New York State Department of Health, AIDS Institute. HIV Counseling & Testing Resource Directory. revised 2001 ed. Available at: http://www.health.state.ny.us/nysdoh/hivaids/hivpartner/resourcedir.htm. Accessed September 16, 2003.
39. New York State Department of Health, AIDS Institute. Directory of ESAP providers in New York State. Available at: http://www.health.state.ny.us/nysdoh/hivaids/esap/provdirect.htm. Accessed September 16, 2003.
40. New York State Department of Health, AIDS Institute. HIV SNPs. Available at: http://www.health.state.ny.us/nysdoh/hivaids/snps/index.htm. Accessed December 15, 2003.
41. New York State Department of Health AIDS Institute, HIV Clinical Resource Office of the Medical Director. A consumer’s guide to quality of HIV care in New York State 1996-1998. Accessed at: http://hivguidelines.org/public_html/center/quality-of-care/qoc-p…/qoc_perform_data_companion.htm. Accessed September 16, 2003.
42. Schmalz J. Fighting on two levels, AIDS Institute Chief has disease. The New York Times. June 13, 1993; 37-44.
43. Centers for Disease Control and Prevention. Adoption of protective behaviors among persons with recent HIV infection and diagnosis—Alabama, New Jersey, and Tennessee, 1997-1998. Morbidity and Mortality Weekly Report. 2000;49:512-515.
44. Centers for Disease Control and Prevention Adoption of protective behaviors among persons with recent HIV infection and diagnosisAlabama, New Jersey, and Tennessee, 1997-1998. Morbidity and Mortality Weekly Report 2000 49 512-515
45. Marks G, Burris S, Peterman TA. Reducing sexual transmission of HIV from those who know they are infected: the need for personal and collective responsibility. AIDS. 1999;13:297-306.
46. Denning PH, Nakashima AK, Wortley P. High-risk sexual behaviors among HIV-infected adolescents and young adults [abstract 113]. Abstracts National HIV Prevention Conference; Atlanta, Georgia; August 29-September 1, 1999.
47. Shalala D. Evidence-based findings on the efficacy of syringe exchange programs [an analysis for the Assistant Secretary for Health and Surgeon General of the Scientific Research Completed Since April, 1998]. Washington DC: Department of Health and Human Services; May 17, 2000.
48. National Institutes of Health. Interventions to prevent HIV risk behaviors. NIH Consensus Statement. 1997;15(2):1-41.
49. National Institutes of Health Interventions to prevent HIV risk behaviors. NIH Consensus Statement 1997 15 2 1-41
50. Centers for Disease Control and Prevention (CDC). Compendium of HIV Prevention Interventions with Evidence of Effectiveness. Atlanta GA: CDC; 1999.
51. Gardner L, Metsch L, Loughlin A, et al. for the ARTAS Study Group. Initial results of the Antiretroviral Treatment Access Studies (ARTAS): efficacy of the case management trial [abstract book 2003, Abstract M3-3B1301]. National HIV Prevention Conference; Atlanta, Georgia; July 27-30, 2003.
52. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of Human Immunodeficiency Virus Type 1—Rakai project study group. The New England Journal of Medicine. 2000;342:921-929.
53. Wade NA, Birkhead GS, Warren BL, et al. Abbreviated Regimens of Zidovudine Prophylaxis and Perinatal Transmission of the Human Immunodeficiency Virus. The New England Journal of Medicine. 1998;339(20):1409-1414.
54. Klein SJ, Birkhead GS, Candelas AR. Commentary: Expanded Syringe Access Demonstration Program (ESAP) in New York State: An Intervention to Prevent HIV Transmission. Journal of Urban Health. 2000;77(4):762-767.
55. Tesoriero JM, French T, Weiss L, et al. Stability of adherence to highly active antiretroviral therapy over time among clients enrolled in the treatment adherence demonstration project. JAIDS. 2003;33:484-493.
56. O’Leary A, Holtgrave D, Wright-De Aquero, Malow RA. Innovations in approaches to preventing HIV/AIDS: applications to other health promotion activities. In: Valdiserri RO, ed. Dawning Answers: How the HIV/AIDS Epidemic Has Helped to Strengthen Public Health. New York NY: Oxford University Press; 2003.
57. Centers for Disease Control and Prevention (CDC). HIV Prevention Strategic Plan Through 2005. Atlanta, GA:CDC; 2001.
58. Holtgrave DO, Pinkerton SD. Economic implications of failure to reduce incident HIV infections by 2005 in the United States. JAIDS. 2003;33:171-174.
59. National Alliance of State and Territorial AIDS Directors (NASTAD). Media Alert: NASTAD Responds to Passage of Spending Bill; Gravely Concerned for Fiscal Well-Bring of State AIDS Drug Assistance Programs. Washington, DC: National Alliance of State and Territorial AIDS Directors; January 22, 2004.